We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERIC ANDA FIRST-FILER DATE TO BE LISTED ON FDA WEBSITE
GENERIC ANDA FIRST-FILER DATE TO BE LISTED ON FDA WEBSITE
March 9, 2004
Generic firms will be able to determine if they are eligible for 180 days of marketing exclusivity under a move by the FDA to disclose the submission dates of the first substantially complete abbreviated new drug applications (ANDAs) challenging brand drug patents.